| || |
Special Internet Prices.
Fast & Guaranteed Worldwide Delivery!
Secure & FAST Online Ordering.
Our Drugstore Is The Most Trusted Online Drug Supplier.
Related post: Branch were moved to the Office of the Director.
There were ten departures from the EAP, either from retirement, movement to
other offices in NIAID or transfer to other BIDs. Dr. Sheffield, formerly
executive secretary of the Allergy, Immunology and Transplantation Research
Committee, moved to the Parasitology Program and was replaced by Dr. Nirmal
Das, formerly Program Director of the Cell Biology Program at the NIA. Mrs.
Margery Grubb has been serving as Committee Management Assistant beginning
this fiscal year. When Dr. Louis Bourgeois retired in August of 1981, the
position of training officer was transferred to the Office of the Director.
Ms. Stesney, Assistant to the Acting Director, EAP, has assumed the duties
of coordinating the R13s, formerly held by Ms. Warfield, in addition to her
other duties. Ms. Warfield has moved to the Office of Program Planning and
The Financial Analysis Section and the Program Analysis and Evaluation
Branch were transferred to the Office of the Director during this fiscal
Other personnel actions are moving very slowly. Ms. Grubb has not had an
assistant since December 1981 and Ms. Stesney has no clerical assistant.
The Acting Director, EAP, has been functioning in that capacity since
January 1981 in addition to her duties as Chief, Program and Project Review
Full-Time Permanent Employees who have left EAP
Merlene Bagley Dorothy Leggin
Linda M. Blazer Frances M. Schlademan
Lila J. Cave Harley Sheffield
Mary Lou Davis William J. Stalters
Carol A. Deakin Mildred S. Warfield
New Full-time Permanent Appointments Awards
Patricia M. Coates Cynthia R. McDermott None
Nirmal K. Das William 0. Mitchell
Judith N. Johnson Mary D. Shryock
C. Committee Management
While a new Committee Management Assistant came on board in August, 1981,
the clerical assistant resigned in December and has not been replaced despite
lengthy recruiting efforts.
Four members retired from the Council as of October 31. The five (one
replacing an earlier resigner) new members did Sinequan 50 Mg not come on board until early
December Buy Sinequan due to a Department hiring freeze. The nomination slate for terms
beginning November 1 has been prepared and is being reviewed by the
Four vacancies on the Board of Scientific Counselors have been filled and
invitations have been issued for members to replace two whose terms expired
Five new members for the Microbiology and Infectious Diseases Advisory
Committee and four for the Allergy, Immunology, and Transplantation Research
Committee (AITRC) began their official duties as of July 1. The nomination
is still pending for a fifth new member of the AITRC.
The Department has initiated a new procedure for reporting and projecting
the cost of operating chartered committees. A Financial Operating Plan
(FOP) is required for each committee, based on calendar year operations with
precise proj'ected costs required for the upcoming year. These FOPs must be
submitted with all charter renewal requests, as well as with other reports
required by the Department.
D. Conference Proposals
Beginning with the September/October 1981 Council cycle, all grant appli-
cations submitted to the NIH for the support of scientific conferences,
workshops and meetings have been handled by the BIDs, through the conference
grant mechanism (R13). Where a mutual interest existed, DRG arranged for
joint sponsorship of a conference by two or more BIDs through multi-Institute
assignment. Initial review was conducted by the primary assignee. All R13
conference grant applications assigned to NIAID during FY 1982 were co-
assigned to at least one other institute. During FY 1982, thirty-four
conference grant applications with NIAID as the primary Institute assignee
received initial peer review for scientific merit by one of the three NIAID
chartered committees (Table II). Following each Council review, recommen-
dations Sinequan 25 Mg for NIAID funding contributions were made by Program staff to members
of the Research Contract Advisory Group (RCAG) for their consideration.
RCAG recommendations were then forwarded to the Director for final approval.
In FY 1982, the amount of NIAID funds set aside for Sinequan 10 Mg partial support of
eighteen conference proposals will not exceed $80,000, or $40,000 for each
of the two major programs. In order to facilitate timely issuance of con-
ference grant awards, this entire process was carefully monitored by the
NIAID conference grant coordinator Ms. Stesney. Actions taken by review,
administrative and management staff, both within NIAID and the other BIDs
identified as cosponsors by DRG, necessitated a continuous collaborative
exchange of information among Institutes concerning all actions involving
the receipt, assignment, review, and funding of these proposals. The NIAID
conference grant coordinator serves as the focal point for all information
about grant applications for the support of scientific meetings by the
NUMBER OF R13 CONFERENCE GRANT APPLICATIONS
REVIEWED BY NIAID, FY 1982*
Approved for Funding
Approved at Fundable Priority
Not Approved for Funding
Approved at Unfundable Priority
AI Primary AI Secondary TOTAL
Related links: Erythromycin Ointment Mgd, doxycycline mgd, Buy Celexa Online Uk, pulmicort respules 1mg, buy doxycycline without rx, buy cheap lisinopril, how to get paxil prescription, trazodone 100 mg get high, cost of generic detrol la, Generic Carvedilol
| || |